Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C.P. Fox
Ncri Petrea Trial: A Phase 3 Evaluation of Pet-Guided, Response-Adapted Therapy in Patients With Previously Untreated, Advanced-Stage, High-Tumour-Burden Follicular Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Improved Survival Outcomes for Patients With Extra-Nodal Nk/T Lymphoma: Data From 140 Patients Prospectively Registered in the International T-Cell Project
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Sakk 35/15: A Phase I Trial of Obinutuzumab in Combination With Venetoclax in Previously Untreated Follicular Lymphoma Patients
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Ongoing Study of Obinutuzumab Short Duration Infusion in Patients With Previously Untreated Advanced Follicular Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Pcn141 - Cost-Effectiveness Analysis of Obinutuzumab for the Treatment of Patients With Previously Untreated Advanced Follicular Lymphoma in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pembrolizumab With Rchop in Previously Untreated Diffuse Large B-Cell and Grade 3b Follicular Lymphoma: Final Results of a Phase I Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
A Phase II Trial of Bendamustine in Combination With Rituximab in Older Patients With Previously Untreated Diffuse Large B-Cell Lymphoma
British Journal of Haematology
Hematology
PET-guided Treatment in Advanced-Stage Hodgkin Lymphoma: Yes but Which One?
Oncotarget
Oncology
Bendamustine and Rituximab in Elderly Patients With Low-Tumour Burden Follicular Lymphoma. Results of the LYSA Phase II BRIEF Study
British Journal of Haematology
Hematology
PET-CT-adapted Therapy for Advanced Hodgkin Lymphoma: A Systematic Review of the Literature
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
2318 Prospective Phase II Trial of Pazopanib Plus CapeOX (Capecitabine and Oxaliplatin) in Previously Untreated Patients With Advanced Gastric Cancer
European Journal of Cancer
Cancer Research
Oncology